Sja Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
- Revenue Growth 50.99%
- Profit Growth 32.06%
- Ebitda 39.25%
- Net Worth 306.05%
- Total Assets 24.12%
About Sja Biotech India
Sja Biotech India Private Limited (SBIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 July 2019 (Five years and six months 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Sagar Singhal, Parul Mehra, Nidhi Gupta, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74110DL2019PTC353187
-
Company No.
353187
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jul 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Sja Biotech India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Singhal
|
Director | 20-Dec-2022 | Current |
|
Parul Mehra
|
Director | 29-Jul-2019 | Current |
|
Nidhi Gupta
|
Director | 19-May-2023 | Current |
|
Ankit Jain
|
Director | 20-Dec-2022 | Current |
Financial Performance of Sja Biotech India.
Sja Biotech India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 50.99% increase. The company also saw a substantial improvement in profitability, with a 32.06% increase in profit. The company's net worth Soared by an impressive increase of 306.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sja Biotech India?
In 2021, Sja Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Cathexis Consulting Private LimitedParul Mehra and Nidhi Gupta are mutual person
-
Singhal Jain & Associates LlpSagar Singhal and Ankit Jain are mutual person
-
Quest Workforce Llp
Sagar Singhal and Ankit Jain are mutual person
-
Bhumidev Infrasolutions Private Limited
Parul Mehra is a mutual person
Charges (Loans)
₹5.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2023 | Hdfc Bank Limited | ₹5.00 Cr | Open |
How Many Employees Work at Sja Biotech India?
Unlock and access historical data on people associated with Sja Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sja Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sja Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
